Science Explorer Interactive view Map
Company · Ornavasso · Italy

Ripamonti

In research, Ripamonti stands highest in Medicine (#5,573 of 17,978 worldwide), Health Sciences (#7,498 of 20,462 worldwide) and Life Sciences (#6,109 of 14,347 worldwide), over all time. Relative to its size it is most specialised in Medicine and Health Sciences — Medicine is 3.8× its share of world research.

ripamonti.netROR OpenAlex
World rank, all time
#11,951
of 42,892
Rank in Italy
#367
of 969
Research works
485
▼ 48% vs 2013–17
Citations
27k
56.0 per fractional work
Top-10% rate
30.9%
record average 16.5%
Open access
35%
world 28%

What is Ripamonti known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #5,573 of 17,978 28.2%293
Health SciencesDomain #7,498 of 20,462 28.0%302
Life SciencesDomain #6,109 of 14,347 32.2%125

Each strip is that field’s whole ranked pool, with the notch where Ripamonti sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Ripamonti specialise in?

Where its research is concentrated relative to its size: Medicine takes 3.8× the share of its output that it takes of world research.

  1. MedicineField · 24.8 works3.8×
  2. Health SciencesDomain · 25.3 works3.2×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.07× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.60× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 3.06× its world share, 1 worksImmunology and Micro…Neuroscience: 0.43× its world share, 0 worksNeuroscienceComputer Science: 0.10× its world share, 0 worksComputer ScienceEnergy: 0.36× its world share, 0 worksEnergyEngineering: 0.23× its world share, 1 worksEngineeringEnvironmental Science: 0.06× its world share, 0 worksEnvironmental ScienceMathematics: 0.16× its world share, 0 worksMathematicsPhysics and Astronomy: 0.14× its world share, 0 worksPhysics and AstronomyDentistry: 0.51× its world share, 0 worksDentistryHealth Professions: 0.38× its world share, 0 worksHealth ProfessionsMedicine: 3.80× its world share, 25 worksMedicineEconomics, Econometrics and Finance: 0.02× its world share, 0 worksEconomics, Econometr…Psychology: 0.39× its world share, 0 worksPsychologySocial Sciences: 0.10× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.

Which keywords describe research at Ripamonti?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Radiotherapy, Clinical Trials, Immunotherapy, Targeted Therapy, Survival Analysis, Tumor Microenvironment and Neoadjuvant Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 39 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 39 words, with their numbers
  1. Chemotherapy5▲ 22×18 topics
  2. Radiotherapy4▲ 32×12 topics
  3. Clinical Trials3▲ 12×5 topics
  4. Immunotherapy3▲ 11×11 topics
  5. Targeted Therapy2▲ 33×4 topics
  6. Quality of Life2▲ 4.7×14 topics
  7. Cancer2▲ 4.8×17 topics
  8. Survival Analysis2▲ 23×6 topics
  9. Breast Cancer2▲ 25×9 topics
  10. Neoadjuvant Therapy2▲ 25×5 topics
  11. Prognostic Factors2▲ 13×11 topics
  12. Tumor Microenvironment2▲ 14×6 topics
  13. Complications2▲ 11×5 topics
  14. Inflammation2▲ 2.7×16 topics
  15. Clinical Practice Guidelines2▲ 9.8×8 topics
  16. Metastasis2▲ 15×9 topics
  17. Epidemiology2▲ 1.22×19 topics
  18. Precision Medicine2▲ 10×4 topics
  19. Biomarkers2▲ 6.5×5 topics
  20. Breast Reconstruction2▲ 75×2 topics
  21. Genomic Profiling2▲ 43×2 topics
  22. Immune Checkpoint Blockade1▲ 36×1 topic
  23. Machine Learning1▲ 1.26×4 topics
  24. PD-1 and PD-L11▲ 36×1 topic
  25. Treatment Guidelines1▲ 18×2 topics
  26. ALK Inhibitors1▲ 55×1 topic
  27. Adjuvant Therapy1▲ 28×2 topics
  28. EGFR Mutations1▲ 55×1 topic
  29. Genetic Mutations1▲ 8.3×7 topics
  30. Medical Imaging1▲ 6.9×3 topics
  31. Prognostic Markers1▲ 33×2 topics
  32. Gene Expression1▲ 5.2×3 topics
  33. Molecular Characterization1▲ 18×4 topics
  34. Tumor Staging1▲ 30×2 topics
  35. Acellular Dermal Matrix1▲ 146×1 topic
  36. CT Screening1▲ 44×1 topic
  37. Lung Cancer1▲ 17×1 topic
  38. Molecular Subtypes1▲ 37×2 topics
  39. Patient-Reported Outcome Measure1▲ 146×1 topic

Which research topics does Ripamonti publish most on?

By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Breast Implant and Reconstruction and Breast Cancer Treatment Studies.

Cancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksLung Cancer Treatments a…1Lung Cancer Treatments and Mutations: 1 fractional worksBreast Implant and Recon…1Breast Implant and Reconstruction: 1 fractional worksBreast Cancer Treatment …1Breast Cancer Treatment Studies: 1 fractional worksLung Cancer Diagnosis and Treatment: 1 fractional worksRadiomics and Machine Learning in Medical Imaging: 1 fractional worksLung Cancer Research Stu…1Lung Cancer Research Studies: 1 fractional worksReconstructive Surgery and Microvascular Techniques: 0 fractional worksProstate Cancer Diagnosis and Treatment: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional works
OncologyPulmonary and Respiratory MedicineSurgeryCancer Research1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 1 works
  2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  3. 3 Breast Implant and Reconstruction Surgery 1 works
  4. 4 Breast Cancer Treatment Studies Cancer Research 1 works
  5. 5 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
  6. 6 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 1 works
  7. 7 Lung Cancer Research Studies Oncology 1 works
  8. 8 Reconstructive Surgery and Microvascular Techniques Surgery 0 works
  9. 9 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  10. 10 Cancer Genomics and Diagnostics Cancer Research 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.2%not open64.8%

World: 28% of research is openly available.

with international co-authors23.2%domestic only76.8%

World: 19% is written across borders.

How has Ripamonti's research output changed?

Output in 2018–2022 was 48% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.